Spanish Version of the KBILD Questionnaire

Pulmonary Fibrosis Clinical Trial

Official title:

Translation Into Spanish of an Interstitial Lung Disease Quality of Life Questionnaire (KBILD)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03103178
• Other study ID #: IIBSP-KBI-2016-47
• Status: Recruiting
• Phase: N/A
• First received: March 23, 2017
• Last updated: March 31, 2017
• Start date: January 2017
• Est. completion date: December 2019

Study information

• Verified date: March 2017
• Source: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of the present study is to advance in the knowledge of quality of life in patients with ILD by translating a ILD quality of life questionnaire.

There are no specific tools validated in Spanish to evaluate the quality of life in patients with ILD, although these measures are useful for an comprensive evaluation of these patients.

Patients with ILD have a significant impact on their health. If we improve our Knowledge of the different domains affected by the disease, and not only in the pathophysiological ones, we will be able to develop tools to improve their management.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 2019
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria

1. Subjects older than 18 years.

2. Diagnosis of ILD, established according to the consensus documents of the ATS and ERS [1,2].

3. Acceptance of the patient to participate in the study by signing the informed consent after having discussed with the researchers the objectives, risks and potential benefits.

Exclusion criteria

1. Another chronic respiratory disease other than EPID.

2. Psychiatric disorder or limitation of collaboration (including language, socio-cultural problem, etc.).

Related Conditions & MeSH terms

• Pulmonary Fibrosis

Intervention

Other:
• Quality of life questionnaire
Measurement of quality of life

Locations

Country	Name	City	State
Spain	Hospital de la Santa Creu i Sant Pau	Barcelona

Sponsors (1)

Lead Sponsor	Collaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Validation of a specific quality of life questionnaire for patients with ILD		6 months